Autopsy and Case Reports
https://autopsyandcasereports.org/article/doi/10.4322/acr.2014.036
Autopsy and Case Reports
Article / Autopsy Case Report

Nodal Epstein-Barr virus-positive T-cell/NK-cell lymphoma associated with immunodeficiency: a rare condition looking for recognition

Cristiane Rúbia Ferreira; Aloísio Felipe-Silva; Fernando Peixoto Ferraz de Campos; Maria Cláudia Nogueira Zerbini

Downloads: 6
Views: 364

Abstract

The authors describe a peculiar form of Epstein-Barr virus (EBV)-associated T-cell lymphoma in an HIV-positive patient presenting an aggressive clinical course. Unlike most other EBV-positive T-cell/natural-killer (NK)-cell lymphomas, the disease was characterized by predominant nodal involvement at presentation. T-cell lineage was confirmed by T-cell receptor-rearrangement, and neoplastic cells exhibited strong and diffuse CD56 expression. A marked intravascular component was detected in the skin, the liver, and the lung parenchyma. This entity was not predicted in the WHO 2008 classification, but has been recently identified in immunocompromised patients. This case report refers to a middle-aged man with AIDS, who presented a 4-month history of weight loss, fever, hepatosplenomegaly, peripheral and deep-chain lymphadenopathy. A blood smear showed lymphocytosis with a marked presence of atypia. The outcome was unfavorable and the patient could not be treated. The autopsy revealed multivisceral involvement, including lymph nodes, spleen, bone marrow, liver, lungs, skin, and kidneys.
 

Keywords

Lymphoma, T-cell, Killer Cells, Natural, Epstein-Barr Virus Infections, Acquired Immunodeficiency Syndrome, Autopsy

References

Bonavida B. NK cell phenotypic and functional heterogeneities and molecular mechanisms of cytotoxicity. Crit Rev Oncog. 2014;19(1-2):21-45. [https://doi.org/10.1615/CritRevOncog.2014010804]. [PMID:24941371]

Kiessling R, Klein E, Wigzell H. “Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol. 1975;5(2):112-7. [https://doi.org/10.1002/eji.1830050208]. [PMID:1234049]

Kiessling R, Klein E, Pross H, Wigzell H. “Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol. 1975;5(2):117-21. [https://doi.org/10.1002/eji.1830050209]. [PMID:1086218]

Herberman RB, Nunn ME, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer. 1975;16(2):216-29. [https://doi.org/10.1002/ijc.2910160204]. [PMID:50294]

Herberman RB, Nunn ME, Holden HT, Lavrin DH. Natural cytotoxic reativity of mouse lymphoid cells against syngeneic acid allogeneic tumors. II. Characterization of effector cells. Int J Cancer. 1975;16(2):230-9. [https://doi.org/10.1002/ijc.2910160205]. [PMID:1080480]

Godfrey DI, Hammond KJL, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today. 2000;21(11):573-83. [https://doi.org/10.1016/S0167-5699(00)01735-7]. [PMID:11094262]

Macon WR, Williams ME, Greer JP, et al. Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood. 1996;87(4):1474-83. [PMID:8608238].

Berzins SP, Smyth MJ, Baxter AG. Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol. 2011;11(2):131-42. [https://doi.org/10.1038/nri2904]. [PMID:21267014]

Vermijlen D, Prinz I. Ontogeny of innate T lymphocytes – some innate lymphocytes are more innate than others. Front Immunol. 2014;5:486. [https://doi.org/10.3389/fimmu.2014.00486]. [PMID:25346734]

Colucci F, Caligiuri MA, Di Santo JP. What does it take to make a natural killer? Nat Rev Immunol. 2003;3(5):413-25. [https://doi.org/10.1038/nri1088]. [PMID:12766763]

Greer JP, Kinney MC, Loughran TP Jr. T cell and NK cell lymphoproliferative disorders. Hematology (Am Soc Hematol Educ Program). 2001;2001(1):259-81. [https://doi.org/10.1182/asheducation-2001.1.259]. [PMID:11722988]

Jaffe ES, Krenacs L, Raffeld M. Classification of cytotoxic T-cell and natural killer cell lymphomas. Semin Hematol. 2003;40(3):175-84. [https://doi.org/10.1016/S0037-1963(03)00132-X]. [PMID:12876666]

Swerdlow SH, Jaffe ES, Brousset P, et al. Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies. Am J Surg Pathol. 2014;38(10):e60-71. [https://doi.org/10.1097/PAS.0000000000000295]. [PMID:25025449]

William BM, Armitage JO. International analysis of the frequency and outcomes of NK/T-cell lymphomas. Best Pract Res Clin Haematol. 2013;26(1):23-32. [https://doi.org/10.1016/j.beha.2013.04.003]. [PMID:23768638]

Raphael M, Said J, Borisch B, Cesarman E, Harris NL. Lymphomas associated with HIV infections. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumors of haematopoietic and lymphoid tissues. IARC: Lyon; 2008; p. 340-2.

Jaffe ES. Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood. 1996;87(4):1207-10. [PMID:8608206].

Emile JF, Boulland ML, Haioun C, et al. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood. 1996;87(4):1466-73. [PMID:8608237].

Jaffe ES, Chan JK, Su I-J, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20(1):103-11. [https://doi.org/10.1097/00000478-199601000-00012]. [PMID:8540601]

Kwong YL, Chan ACL, Liang RH. Natural killer cell lymphoma/leukemia: pathology and treatment. Hematol Oncol. 1997;15(2):71-9. [https://doi.org/10.1002/(SICI)1099-1069(199705)15:2<71::AID-HON601>3.0.CO;2-U]. [PMID:9375032]

Lima M. Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis. Orphanet J Rare Dis. 2013;8(1):95-104. [https://doi.org/10.1186/1750-1172-8-95]. [PMID:23816348]

Gualco G, Domeny-Duarte P, Chioato L, Barber G, Natkunam Y, Bacchi CE. Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis. Am J Surg Pathol. 2011;35(8):1195-203. [https://doi.org/10.1097/PAS.0b013e31821ec4b5]. [PMID:21716086]

Li S, Feng X, Li T, et al. Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center. Am J Surg Pathol. 2013;37(1):14-23. [https://doi.org/10.1097/PAS.0b013e31826731b5]. [PMID:23232851]

Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood. 2009;113(17):3931-7. [https://doi.org/10.1182/blood-2008-10-185256]. [PMID:19029440]

Chan JKC, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood. 1997;89(12):4501-13. [PMID:9192774].

Chim CS, Ma ESK, Loong F, Kwong YL. Diagnostic cues for natural killer cell lymphoma: primary nodal presentation and the role of in situ hybridisation for Epstein-Barr virus encoded early small RNA in detecting occult bone marrow involvement. J Clin Pathol. 2005;58(4):443-5. [https://doi.org/10.1136/jcp.2004.022608]. [PMID:15790718]

Takahashi E, Asano N, Li C, et al. Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases. Histopathology. 2008;52(5):585-96. [https://doi.org/10.1111/j.1365-2559.2008.02997.x]. [PMID:18370955]

Chang ST, Liao YL, Lin SH, Chuang SS. NK-cell lymphoma with nodal presentation and expression of cutaneous lymphocyte-associated antigen. Pathol Res Pract. 2010;206(7):463-6. [https://doi.org/10.1016/j.prp.2009.07.001]. [PMID:19628338]

Cheuk W, Chan JKC. NK-Cell neoplasms. In: Jaffe ES, Harris NL, Vandiman JW, Campo E, Arber DA, editors. Hematopathology. Philadelphia: Elsevier Saunders; 2011. p. 486-90.

Suzuki R, Suzumiya J, Nakamura S, et al. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia. 2004;18(4):763-70. [https://doi.org/10.1038/sj.leu.2403262]. [PMID:14961041]

Ruskova A, Thula R, Chan G. Aggressive Natural Killer-Cell Leukemia: report of five cases and review of the literature. Leuk Lymphoma. 2004;45(12):2427-38. [https://doi.org/10.1080/10428190400004513]. [PMID:15621755]

Zhang H, Meng Q, Yin W, Xu L, Lie L. Adult aggressive natural killer cell leukemia. Am J Med Sci. 2013;346(1):56-63. [https://doi.org/10.1097/MAJ.0b013e3182764b59]. [PMID:23241562]

Attygalle AD, Cabeçadas J, Gaulard P, et al. Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology. Histopathology. 2014;64(2):171-99. [https://doi.org/10.1111/his.12251]. [PMID:24128129]

Oh SC, Choi CW, Kim BS, et al. NK/T-cell lymphoma associated with Epstein-Barr virus in a patient infected with human immunodeficiency virus: an autopsy case. Int J Hematol. 2004;79(5):480-3. [https://doi.org/10.1532/IJH97.A10316]. [PMID:15239400]

Panarelli NC, Furman RR, Wang YL, Elstrom R, Cohen JA, Chadburn A. NK/T cell non-Hodgkin lymphoma in a HIV-positive patient. J Hematop. 2010;3(1):35-40. [https://doi.org/10.1007/s12308-010-0057-5]. [PMID:21373175]

Nagahata Y, Kato A, Imai Y, Ishikawa T. HIV-related NK/T-cell lymphoma in the brain relapsed during intensive chemotherapy but regressed after chemotherapy discontinuation: the importance of maintaining cellular immunity. Int J Hematol. 2014;100(4):402-6. [https://doi.org/10.1007/s12185-014-1610-2]. [PMID:24938379]

Canioni D, Arnulf B, Asso-Bonnet M, Raphael M, Brousse N. Nasal natural killer lymphoma associated with Epstein-Barr virus in a patient infected with human immunodeficiency virus. Arch Pathol Lab Med. 2001;125(5):660-2. [PMID:11300939].


 


Publication date:
01/13/2016

569696b764cc8b5cda711c0a autopsy Articles

Autops Case Rep

Share this page
Page Sections